🇺🇸 FDA
Patent

US 8658622

Methods and compositions for preventing and treating a disease related to glycan dysregulation

granted A61KA61K31/593A61K31/70

Quick answer

US patent 8658622 (Methods and compositions for preventing and treating a disease related to glycan dysregulation) held by The Regents of the University of California expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/593, A61K31/70, A61K31/7008, A61K31/7072